Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome. Graeme L Fraser et al

18/08/2021,

Serge Rozenberg

Next meeting

22/11/2025

Title “(Peri-) Menopause Pain”

10/06/2025

Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer by Fatima Cardoso, et al (NEJM June 2, 2025 DOI: 10.1056/NEJMoa2415566